Active ingredient: HMG Driada Medical Human Menopausal Gonadotropin (hMG). Each vial contains highly-purified human menopausal gonadotrophin (HMG) corresponding to 75 IU of follicle-stimulating hormone (FSH) and 75 IU of luteinizing hormone (LH).
Type: Peptide hormone
Form: Injections

HMG Driada Medical Human Menopausal Gonadotropin for sale

HMG A hormonally active drug called Driada Medical Human Menopausal Gonadotropin, or hMG, is used to treat problems with male and female fertility. Follicle stimulating hormone (FSH) and luteinizing hormone (LH) are two gonadotropins combined.

Human Menopausal Gonadotropin Mechanism of action

Following injection, HMG Driada Medical Human Menopausal Gonadotropin enters your body through the muscle tissue and is released. Because HMG can be taken regularly to increase your body’s production of testosterone, anti-aging clinics, and biotechnology businesses have found great success with it.

Unlike HCG, which primarily attaches to LH receptors (Leydig cells) and very little to FSH receptors (Sertoli cells), HMG Driada Medical Human Menopausal Gonadotropin more naturally binds to both LH and FSH receptors.

HMG Driada Medical and Testosteron

In addition to increasing intratesticular testosterone, HMG Driada Medical Human Menopausal Gonadotropin encourages sperm differentiation and maturation.

FSH, present in HMG Driada Medical Human Menopausal Gonadotropin, significantly impacts spermatozoid production, testicular growth, libido, and mood. Affective problems are also a result of a deficiency in FSH signaling.

The kidneys are the main organ responsible for excreting HMG Driada Medical Human Menopausal Gonadotropin. There has yet to be any research done on the pharmacokinetics of HMG in individuals with liver or renal impairment.

Purpose to using Human Menopausal Gonadotropin

Although it was created to treat female infertility, men can use it while undergoing hormone replacement therapy. Bodybuilders have been using HMG Driada Medical Human Menopausal Gonadotropin extensively to enhance post-cycle therapy greatly. HMG Driada Medical Human Menopausal Gonadotropin is used as the source of FSH to stimulate and preserve the Sertoli cells. In contrast, HCG is the source of luteinizing hormone (LH) bioactivity that stimulates testosterone secretion by Leydig cells to support their activity and prevent atrophy.

Preserving the testicle’s function, preventing total ultimate atrophy, and maintaining the steroidogenesis cascade—which generates a plethora of secondary hormones and chemicals crucial to mental and physical health—are all essential during the anabolic steroid cycle.

Facts about Human Menopausal Gonadotropin

During the cycle or PCT, HMG Driada Medical Human Menopausal Gonadotropin offers complete stimulation of testicular function. Research revealed that even after lengthy steroid cycles and during TRT, HMG Driada Medical Human Menopausal Gonadotropin, in combination with HCG, does restore fertility. A recent meta-analysis demonstrated that post-cycle recovery is better when hCG and HMG are coupled.

HMG Driada Medical How to use

HMG therapy Driada Medical should be started under the guidance of a doctor skilled in treating infertility issues. The way that the ovaries react to exogenous gonadotrophins varies significantly between individuals. It is, therefore, impossible to establish a consistent dose schedule. Thus, each person’s dosage must be modified based on their unique ovarian response. HMG can be administered on its own or in conjunction with an agonist or antagonist of GnRH. Depending on the actual treatment protocols, recommendations about therapy duration and dosage may vary:

HMG Driada Medical must be administered in cycles longer than ten weeks to maintain testicular function and fertility. It is best to start using it during the first week to prevent any testicular atrophy. Preventing testicular atrophy usually starts three to four weeks into the steroid cycle. In any event, processes longer than ten weeks result in a total loss of testicular functioning, so it’s imperative to begin HCGHMG treatment as soon as feasible. The protocol in this instance is 250–500 IU/2–3 times per week for HCG and 75–150 IU for HMG.

Dosage and Usage

It is advised that individuals with hypogonadotropic hypogonadism take up to 5–10 IU daily for a few months.

Up to 10 IU can be taken daily by athletes looking for a solution to increase their performance. You can take an extra 5 IU dose 30 minutes before working out on days when you work out.

The human menopausal gonadotropin and human chorionic gonadotropin protocol, when used in cases of severe anabolic steroid-induced azoospermia, consists of twice-weekly injections of 10,000 IU of HCG and daily injections of 75 IU of HMG for three months. It is crucial to avoid overusing since this may cause the Leydig cells to become overstimulated.

How to prepare a solution with HMG Driada Medical

A syringe pre-filled with diluent is used to make a solution for an HMG Driada Medical injection, which is then injected into a vial containing lyophilized powder. Make sure the needle reaches the bottle wall by tilting the container. Do not directly inject the diluent into the powder that has been lyophilized. Take your time and fill the bottle one at a time; the solvent should gradually run down the wall. After adding all the diluents to the peptide vial, stir gently (do not shake or agitate the vial) until the lyophilized powder dissolves and the liquid becomes clear. The medication can now be used.

Never combine different peptides in the same syringe. This may break delicate peptide molecules.

Application

The injection can be subcutaneous, intramuscular, depending on personal preferance.

Bodybuilder Effects from HMG Driada Medical

Increased levels of endogenous testosterone
Increased production spermatozoids
Increased libido and mood
Fertility restoration
Preservation of testicles activity during the cycle
The possibility of restoring the production of one’s own testosterone and fertility after abusive steroid abuse

Negative Side effects from HMG Driada Medical

Abdominal pain
Shortness of breath
Breast swelling
Tender breasts
Nausea
Weight gain
Swelling of the hands and feet
Mild skin rash
Testicular pain

Product Drug profile

Half-life: LH (half-life 13.8–1020 min) and FSH (half-life 21.3–1090 min)
Frequency of intake: 1 time 3 days

Human Menopausal Gonadotropin Contraindications

Hypersensitivity to menotrophin or to any of the excipients of Menopur.
Women who have: Tumours of the pituitary gland or hypothalamus; ovarian, uterine or mammary carcinoma; gynaecological haemorrhage of unknown aetiology; ovarian cysts or enlarged ovaries not due to polycystic ovarian disease.
In the following situations treatment outcome is unlikely to be favourable, and therefore, HMG should not be administered: Primary ovarian failure; malformation of sexual organs incompatible with pregnancy; fibroid tumours of the uterus incompatible with pregnancy.
Use in pregnancy
HMG is contraindicated in women who are pregnant.
There are no or limited amount of data from the use of menotrophins in pregnant women. No animal studies have been carried out to evaluate the effects of Menopur during pregnancy.
Use in lactation
HMG is contraindicated in women who are lactating.

Menotropin Injections

Menotropin Injections could be made subcutaneously and intramuscularly with an insulin syringe.
Disinfect the rubber cap of the drug and the injection site with alcohol.
Draw the drug into a syringe and inject it slowly.

Correct Storage for Menotropin

Store protected from light
Store in a refrigerator (2-8°C)
Do not freeze
After reconstitution, the solution may be stored for a maximum of 28 days at not >25°C
After dissolution in the included solvent, the solution should be administered immediately
Keep away from children
Do not use after the expiry date